Skip to main content

Table 2 Statistical analyses of predictors for the 5-year PSA relapse-free survival, p values

From: Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan

 

UA

MA

NCCN risk (IR vs. HR)

0.01*

0.96

GS (8–10 vs. < 8)

<0.001*

0.044*

ADT (yes vs. no)

0.1

0.967

ADT duration (continuous)

0.452

0.549

STADT vs. LTADT

0.477

0.513

Pretreatment PSA (≤20 vs. >20)

0.046*

0.29

PLND (yes vs. no)

0.316

0.454

  1. Abbreviations: UA, univariate analysis; MA, multivariate analysis; *, statistical significance; PLND, pelvic lymph node dissection; other abbreviations as in Table1.